Literature DB >> 6894819

Treatment of acute maxillary sinusitis. V. Amoxicillin azidocillin, phenylpropanolamine and pivampicillin.

A Axelsson, C Jensen, O Melin, F Singer, C von Sydow.   

Abstract

One hundred and seventy-five patients with clinical symptoms of acute maxillary sinusitis, the diagnosis confirmed radiologically by mucous membrane thickening and secretion, were consecutively allocated to four different treatment groups: amoxicillin, azidocillin, phenylpropanolamine, and pivampicillin. The cure course was followed up radiologically on days 5, 10, and 15. The outcome of treatment was somewhat more beneficial after 5 days for amoxicillin and after 10 days for azidocillin, but slightly less beneficial with phenylpropanolamine after 10 and 15 days. The numbers of side effects were similar for the different treatment groups. The four treatment modes in question are compared with 19 others previously used in a large material consisting of more than 1000 patients with acute maxillary sinusitis.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 6894819     DOI: 10.3109/00016488109138513

Source DB:  PubMed          Journal:  Acta Otolaryngol        ISSN: 0001-6489            Impact factor:   1.494


  5 in total

Review 1.  [Diseases of the paranasal sinuses and their relation to respiratory tract diseases].

Authors:  H G Wiesemann; U Stephan
Journal:  Arch Otorhinolaryngol       Date:  1982

Review 2.  Current diagnosis and management of sinusitis.

Authors:  L R Willett; J L Carson; J W Williams
Journal:  J Gen Intern Med       Date:  1994-01       Impact factor: 5.128

3.  Management of sinusitis. Is a self limiting condition.

Authors:  M De Meyre
Journal:  BMJ       Date:  1995-03-11

4.  Amoxicillin concentrations in nasal secretions of patients with acute uncomplicated sinusitis and in paranasal sinus mucosa of patients with chronic sinusitis.

Authors:  G Kment; A Georgopoulos; W Ridl; J Mühlbacher
Journal:  Eur Arch Otorhinolaryngol       Date:  1995       Impact factor: 2.503

5.  Amoxicillin plus clavulanic acid in the treatment of recurrent urinary tract infections.

Authors:  W Brumfitt; J M Hamilton-Miller
Journal:  Antimicrob Agents Chemother       Date:  1984-02       Impact factor: 5.191

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.